
    
      To determine whether HBeAg-positive and HBeAg-negative patients with HBV DNA greater than or
      less than 5 log10 and 4 log10 copies/mL, respectively, and with normal or minimally elevated
      liver transaminases have histological evidence of active liver disease.
    
  